Entoptic perimetry screening for central diabetic scotomas and macular edema

Ophthalmology

Volumn 107, Issue 4, 2000, Pages 755-759

  Brown, Justin C ^a   Kylstra, Jan A ^a   Mah, May Ling ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLINDNESS; DIABETES MELLITUS; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIMETRY; PRIORITY JOURNAL; RETINA MACULA EDEMA; SCOTOMA; SCREENING TEST; VISION TEST; VISUAL IMPAIRMENT;

ADULT; AGED; DIABETES COMPLICATIONS; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; PERIMETRY; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SCOTOMA; SENSITIVITY AND SPECIFICITY; VISION SCREENING; VISUAL ACUITY; VISUAL FIELDS;

EID: 0034112969     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)00149-9     Document Type: Article

References (26)

1. National Society to Prevent Blindness Operational Research Department. Vision Problems in the U.S. New York: The Society, 1980; 18.
2. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 1978;85:82-106.
3. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 1. Early Treatment of Diabetic Retinopathy Study. Arch Ophthalmol 1985;103:1796-806.
4. Diabetic Retinopathy. Preferred Practice Pattern. San Francisco, CA: American Academy of Ophthalmology, 1998;10-4.
5. Brechner R.J., Cowie C.C., Howie L.J., et al. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA. 270:1993;1714-1718.
6. Silverstone D.E., Hirsch J. Automated Visual Field Testing Techniques of Examination and Interpretation . 1986;256 Appleton-Century-Crofts, East Norwalk, Conn.
7. Schatz H., McDonald H.R., Johnson R.N. Diabetic Retinopathy For My Patient . 1998;16-17 The Retina Research Fund, San Francisco, CA.
8. Humphrey Field Analyzer II User's Guide. 1994;Humphrey Instruments Inc, San Leandro, CA.
9. Caprioli J. Automated perimetry in glaucoma. Walsh T.J. Visual Fields Examination and Interpretation . 1990;88 American Academy of Ophthalmology, San Francisco, CA.
10. Ramachandran V.S., Gregory R.L. Perceptual filling in of artificially induced scotomas in human vision. Nature. 350:1991;699-702.
11. Aulhorn E., Köst G. Rauschfeld kampimetrie. Eine heuartige perimetrische untersuchungsweise [Eng. abstr.]. Klin Monatsbl Augenheilkd. 192:1988;284-288.
12. Ramachandran V.S. Blind spots. Sci Am. 266:1992;86-91.
13. Plummer D.J., Arevalo J.F., Fram N., et al. Effectiveness of entoptic perimetry for locating peripheral scotomas caused by cytomegalovirus retinitis. Arch Ophthalmol. 114:1996;828-831.
14. Amsler M. Earliest symptoms of diseases of the macula. Br J Ophthalmol. 37:1953;521-537.
15. Feldon SE. Visual fields in retinal disease. In: Ryan S editor-in-chief. Retina, 2nd ed. Vol 1, St Louis, MO: Mosby, 1994;153-4.
16. Wall M., Sadun A.A. Threshold Amsler grid testing cross-polarizing lenses enhance yield . Arch Ophthalmol. 104:1986;520-523.
17. Schuchard R.A. Validity and interpretation of Amsler grid reports. Arch Ophthalmol. 111:1993;776-780.
18. Fine S.L. Early detection of extrafoveal neovascular membranes by daily central field evaluation. Ophthalmology. 92:1985;603-609.
19. Roy M.S. Vision loss without Amsler grid abnormalities in macular subretinal neovascularization. Ophthalmologica. 191:1985;215-217.
20. Drance SM. Computerized Visual Fields: the Evolution of Perimetry. Thorofare, NJ: Slack Inc., 1985;5-9.
21. Slavin M.L. The use of the red Amsler grids and red-green lenses in detecting spurious paracentral visual field defects [letter]. Am J Ophthalmol. 103:(3 Pt 1):1987;338-339.
22. Easterbrook M. Comparison of threshold and standard Amsler grid testing in patients with established antimalarial retinopathy. Can J Ophthalmol. 27:1992;240-242.
23. Wall M., May D.R. Threshold Amsler grid testing in maculopathies. Ophthalmology. 94:1987;1126-1133.
24. Wall M., Collins C., May D.R. Low-intensity grids improve sensitivity of Amsler grid testing in diabetic patients without background retinopathy. Ann Ophthalmol. 22:1990;96-100.
25. Wolfe K.A., Sandun A.A. Threshold Amsler grid testing in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 229:1991;219-223.
26. Achard O.A., Safran A.B., Duret F.C., Ragama E. Role of the completion phenomenon in the evaluation of Amsler grid results. Am J Ophthalmol. 120:1995;322-329.